MFDS — authorised 19 February 2002
- Marketing authorisation holder: SPECTRUM PHARMS
- Status: likely_approved
🇰🇷 Zevalin in South Korea
MFDS authorised Zevalin on 19 February 2002
Marketing authorisation
Zevalin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Zevalin approved in South Korea?
Yes. MFDS authorised it on 19 February 2002.
Who is the marketing authorisation holder for Zevalin in South Korea?
SPECTRUM PHARMS holds the South Korean marketing authorisation.